These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 7837147

  • 1. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Vancheeswaran R, Magoulas T, Efrat G, Wheeler-Jones C, Olsen I, Penny R, Black CM.
    J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
    [Abstract] [Full Text] [Related]

  • 2. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Morelli S, Ferri C.
    J Rheumatol; 1996 Apr; 23(4):789-91. PubMed ID: 8730152
    [No Abstract] [Full Text] [Related]

  • 3. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Gordon MM, Madhok R.
    J Rheumatol; 1996 Apr; 23(4):788-9. PubMed ID: 8730151
    [No Abstract] [Full Text] [Related]

  • 4. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon.
    Blann AD, Illingworth K, Jayson MI.
    J Rheumatol; 1993 Aug; 20(8):1325-30. PubMed ID: 8230013
    [Abstract] [Full Text] [Related]

  • 5. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
    Young-Min SA, Beeton C, Laughton R, Plumpton T, Bartram S, Murphy G, Black C, Cawston TE.
    Ann Rheum Dis; 2001 Sep; 60(9):846-51. PubMed ID: 11502611
    [Abstract] [Full Text] [Related]

  • 6. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
    Nihtyanova SI, Tang EC, Coghlan JG, Wells AU, Black CM, Denton CP.
    QJM; 2010 Feb; 103(2):109-15. PubMed ID: 19966313
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis.
    Asano Y, Ihn H, Kubo M, Jinnin M, Mimura Y, Ashida R, Tamaki K.
    Rheumatology (Oxford); 2006 Mar; 45(3):303-7. PubMed ID: 16278285
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
    Yamane K, Ihn H, Kubo M, Yazawa N, Kikuchi K, Soma Y, Tamaki K.
    J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
    [Abstract] [Full Text] [Related]

  • 9. Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
    Carulli MT, Handler C, Coghlan JG, Black CM, Denton CP.
    Ann Rheum Dis; 2008 Jan; 67(1):105-9. PubMed ID: 17604287
    [Abstract] [Full Text] [Related]

  • 10. Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis.
    Hara T, Ogawa F, Yanaba K, Iwata Y, Muroi E, Komura K, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    J Rheumatol; 2009 Jan; 36(1):99-105. PubMed ID: 19208531
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
    Asano Y, Ihn H, Yamane K, Yazawa N, Kubo M, Fujimoto M, Tamaki K.
    Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
    [Abstract] [Full Text] [Related]

  • 12. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Ramos-Casals M, Campillo-Grau M, García-Hernández FJ, Castillo-Palma MJ, Sánchez-Román J, Callejas-Rubio JL, Ortego-Centeno N, Egurbide-Arberas MV, Trapiellla-Martínez L, Gallego-Villalobos M, Sáez-Comet L, Velilla-Marco J, Camps-García MT, de Ramón-Garrido E, Esteban Marcos EM, Pallarés-Ferreres L, Hidalgo-Tenorio C, Sabio-Sánchez JM, Gómez-de la Torre R, Salvador-Cervello G, Rios-Blanco JJ, Gil-Aguado A, Vilardell-Tarrés M.
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [Abstract] [Full Text] [Related]

  • 13. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.
    Sacks DG, Okano Y, Steen VD, Curtiss E, Shapiro LS, Medsger TA.
    J Rheumatol; 1996 Apr; 23(4):639-42. PubMed ID: 8730118
    [Abstract] [Full Text] [Related]

  • 14. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
    Yanaba K, Komura K, Kodera M, Matsushita T, Hasegawa M, Takehara K, Sato S.
    Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498
    [Abstract] [Full Text] [Related]

  • 15. Localization of endothelin-1 and its binding sites in scleroderma skin.
    Vancheeswaran R, Azam A, Black C, Dashwood MR.
    J Rheumatol; 1994 Jul; 21(7):1268-76. PubMed ID: 7525957
    [Abstract] [Full Text] [Related]

  • 16. Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.
    Yanaba K, Yoshizaki A, Muroi E, Hara T, Ogawa F, Usui A, Hasegawa M, Fujimoto M, Takehara K, Sato S.
    J Rheumatol; 2009 Aug; 36(8):1657-62. PubMed ID: 19531747
    [Abstract] [Full Text] [Related]

  • 17. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis.
    Kodera M, Hasegawa M, Komura K, Yanaba K, Takehara K, Sato S.
    Arthritis Rheum; 2005 Sep; 52(9):2889-96. PubMed ID: 16142750
    [Abstract] [Full Text] [Related]

  • 18. Elevated plasma adrenomedullin and vascular manifestations in patients with systemic sclerosis.
    Mok MY, Cheung BM, Lo Y, Leung RY, Wong WS, Lau CS.
    J Rheumatol; 2007 Nov; 34(11):2224-9. PubMed ID: 17937467
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.
    Jinnin M, Makino T, Kajihara I, Honda N, Makino K, Ogata A, Ihn H.
    Br J Dermatol; 2010 Apr; 162(4):751-8. PubMed ID: 19886888
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.